Pinpoint Asset Management (Singapore)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Buy
11,009
+1,399
+15% +$412K 0.64% 25
2026
Q1
$2.85M Buy
9,610
+5,236
+120% +$1.69M 0.66% 27
2025
Q4
$1.33M Hold
4,374
0.28% 31
2025
Q3
$1.49M Sell
4,374
-11,926
-73% -$3.62M 0.27% 40
2025
Q2
$3.95M Buy
+16,300
New +$4M 0.69% 27

Other funds holding ONC

Pinpoint Asset Management (Singapore)'s ONC Position: Q2 2026 in Review

Pinpoint Asset Management (Singapore) increased its BeOne Medicines Ltd (ONC) stake by 15% in Q2 2026, buying an estimated $412K and bringing the position to 11,009 shares worth $3.14M. The position accounts for 0.64% of the portfolio, ranked #25.

Pinpoint Asset Management (Singapore) first reported a position in ONC in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.95M in Q2 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Pinpoint Asset Management (Singapore) held 11,009 shares of BeOne Medicines Ltd worth $3.14M as of Q2 2026.
  • Pinpoint Asset Management (Singapore) bought 1,399 BeOne Medicines Ltd shares in Q2 2026, an estimated $412K.
  • BeOne Medicines Ltd made up 0.64% of Pinpoint Asset Management (Singapore)'s portfolio in Q2 2026, its #25 holding.
  • Pinpoint Asset Management (Singapore) first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 5 quarters since.
  • Pinpoint Asset Management (Singapore)'s BeOne Medicines Ltd position peaked at $3.95M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Pinpoint Asset Management (Singapore)'s 13F filing for Q2 2026, filed 6 Aug 2026.